Exicure, Inc. , a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology.
Exicure stock last closed at $6.85, down 2.92% from the previous day, and has increased 267.4% in one year. It has overperformed other stocks in the Biotechnology industry by 3.31 percentage points. Exicure stock is currently +375.69% from its 52-week low of $1.44, and -80.97% from its 52-week high of $36.00.
As of Aug 14, 2025, there are 6.32M XCUR shares outstanding. The market cap of XCUR is $43.28M. In the past 24 hours, 4200 XCUR shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy XCUR shares.
Based on our research, eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, you need to fill out some personal information so you are able to invest in XCUR today.
Now that you have finished signing up on app for stock market, you need to deposit funds:
Watch the walkthrough below to see the process of depositing funds into your new brokerage account.
After you have chosen the best place to buy Exicure stock, it's very important to research their stock prior to investing, so you can understand the risk and upside.
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on XCUR's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge XCUR's fair value.
Using relative valuations metrics:
You can access more valuation research on XCUR's stock here.
Last year, XCUR revenue was $0.00. Over the last five year, XCUR's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 63.37%.
You can analyze XCUR's earnings and revenue performance here.
In the past 12 months, executives and large shareholders at XCUR have bought more shares than they have sold.
Josh Miller, Chief Accounting Officer of XCUR, was the latest XCUR insider to sell. They sold $80.48 worth of XCUR shares on May 16, 2025.
Get more info about who owns XCUR stock here.
No, Exicure doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
There are two primary order types:
Press the Open Trade button and eToro will execute your order.
If you require additional info about investing in stocks on eToro, watch the how to video below:
Now that you own some shares in XCUR, you'll want to keep up with your stock purchase.
Start a watchlist to see the latest developments about your XCUR stock.
To summarize, here are the 6 steps for buying Exicure stock:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Exicure, create a watchlist today.